Singapore, July 17 -- Hyphens Pharma, a subsidiary of Hyphens Pharma International Limited, Singapore's leading specialty pharmaceutical and consumer healthcare group, has announced the launch of Winlevi (clascoterone) cream 1% in Singapore and Malaysia, marking its first entry into Southeast Asia.

This launch is made possible through an exclusive license and supply agreement with Cassiopea S.p.A., a subsidiary of Cosmo Pharmaceuticals N.V. The agreement covers Winlevi and its future product extensions and improvements across 10 Southeast Asian countries (Singapore, Malaysia, Indonesia, Philippines, Vietnam, Thailand, Brunei, Cambodia, Laos and Myanmar).

Winlevi is the first new class of molecule in acne treatment in over 40 years, acti...